Caxton Associates (UK)’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Sell
4,845
-1,986
-29% -$538K 0.03% 319
2025
Q4
$1.71M Hold
6,831
0.03% 239
2025
Q3
$1.96M Buy
6,831
+4,166
+156% +$1.12M 0.05% 205
2025
Q2
$700K Sell
2,665
-8,399
-76% -$2.05M 0.02% 367
2025
Q1
$2.58M Buy
+11,064
New +$2.68M 0.09% 111

Other funds holding LH

Caxton Associates (UK)'s LH Position: Q1 2026 in Review

Caxton Associates (UK) reduced its Labcorp (LH) stake by 29% in Q1 2026, selling an estimated $538K and leaving 4,845 shares worth $1.29M. The position accounts for 0.03% of the portfolio, ranked #319.

Caxton Associates (UK) first reported a position in LH in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.58M in Q1 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Caxton Associates (UK) held 4,845 shares of Labcorp worth $1.29M as of Q1 2026.
  • Caxton Associates (UK) sold 1,986 Labcorp shares in Q1 2026, an estimated $538K.
  • Labcorp made up 0.03% of Caxton Associates (UK)'s portfolio in Q1 2026, its #319 holding.
  • Caxton Associates (UK) first reported a position in Labcorp in Q1 2025 and has held it in 5 quarters since.
  • Caxton Associates (UK)'s Labcorp position peaked at $2.58M in Q1 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.